Gastroenterology Flashcards
Clostridioides difficiles pathophysiology and features
G +ve, spore-forming, toxin-producing bacillus
RF: PPIs, clindamycin, second-third gen cephalosporins leading cause
Faeco-oral transmission via spores
Exotoxin A and B acts on epithelial cells and inflammatory cells –> colitis
Diarrhoea, abdo pain, raised WCC
Risk of toxic megacolon
C Diff severity scale
Public Health England severity scale:
Mild: normal WCC
Mod:
- WCC<15
- 3-5 loose stools/day
Severe:
- WCC>15 or
- raised creat (>50% baseline)
- Temperature >38.5
- or Evidence of severe colitis
Life-threatening:
- Hypotension
- Partial/complete ileus
- Toxic megacolon
- Radiological evidence of severe disease
How to diagnose C Diff
C Diff toxin (CDT) in stool
C Diff antigen only shows exposure
C Diff treatment
Isolation until 48hrs post last diarrhoea, gloves + apron + hand washing
1st episode:
1. oral vanc 10 days
2. oral fidaxomicin
3. oral vanc +/- IV metron
Recurrent: (in 20% of patients, rises to 50% after 2nd episode)
within 12 weeks of symptom resolution: oral fidaxomicin
after 12 weeks of resolution: oral vanc or fidaxomicin
Life threatening:
oral vanc + IV metro + specialist advice ?surgical
Others:
- bezlotoxumab (targets exotoxin B, not cost-effective according to NICE)
- faecal microbiota transplant (for 2 or more episodes)
What is Eosinophilic oesophagitis?
Allergic inflamation of oesophagus likely secondary to allergic reaction to ingested food
How does eosinophilic oesophagitis present?
-pain, dysphagia
-strictures/fibrosis (56%)
-food impaction (55%)
-regurgitation/vomiting
-anorexia, weight loss
- failure to thrive in children
Risk factors for eosinophilic oesophagitis
atopy/allergies/asthma, males (3:1), FHx of atopy, Caucasians, ages 30-50, coexisting autoimmune PMH
How do you investigate and diagnose eosinophilic oesophagitis
Endoscopy with biopsy - eosinophils>15 per high power microscopy field
PPI trial - no improvement, persistence of eosinophilia
Biopsy findings for eosinophilic oesophagitis
- dense eosinophilic epithelial infiltration
- > 15 eosinophils per high power microscopy field for diagnosis
Others:
- reduced vasculature, thick mucosa, mucosal furrows, strictures, laryngeal oedema
- epithelial desquamation, eosinophilic microabscesses, abnormally long papillae
How to manage eosinophilic oesophagitis
- Refer to Gastro
Diet: (3 methods)
- elemental diet involving amino acid mixture 6 weeks
- exclusion of 6 food groups associated with allergy
- targetted elimination diet (exclude foods identified as allergy-triggering using allergy testing)
(involve dietician)
Meds:
- topical oral steroids - fluticasone, budesonide 8 weeks then reassessment
Radical:
-oesophageal dilatation: 56% require this at some point to reduce burden from strictures
Complications and prognosis of eosinophilic oesophagitis
- Strictures (56%)
- Impaction (55%), 38% require endoscopic removal of impaction
- Mallory-Weiss tears
px: chroic, comes back if treatment stopped
What is Gilbert’s syndrome
autosomal recessive deficiency of UDP glucuronosyltransferase resulting in defective bilirubin conjugation
unconjugated bilirubinaemia, exacerbated by illness/infection, exercise, fasting
How to investigate and manage Gilbert’s syndrome
rise in bilirubin after fasting
- IV nicotinic acid test with exaggerated rise in unconjugated bilirubin
no treatment required
What is SBBOS
Small bowel bacterial overgrowth syndrome, resulting in GI symptoms, with lots of overlap with IBS symptoms incl diarrhoea, bloating, flatulence, abdo pain
Risk factors for SBBOS
- congenital, neonatal GI abnormalities
- scleroderma
- diabetes mellitus
Diagnosing SBBOS
Hydrogen breath test
small bowel aspiration, culture (invasive, difficult)
?abx trial
Managing SBBOS
- correct underlying cause
- Rifaximin trial (co-amox/metro can also be used in majority)
PBC
primary biliary cholangitis/cirrhosis
(M rule - IgM, aMa M2 subtype, Middle aged females)
- chronic inflammation dmaaging interlobular bile ducts –> cholestasis –> cirrhosis
Itching in middle aged females (9:1), fatigue, cholestatic jaundice, raised ALP
- Hyperpigmentation on pressure points
- RUQ pain in 10%
- xanthelasma/xanthomata
- clubbing, hepatosplenomegaly
- can lead to liver failure
Assx: Sjogren’s (80%), RhArth, Systemic sclerosis, thyroid disorders
Ix:
- AMA M2 subtype (98%)
- sm antibodies 30%
- raised IgM
- Exclude extrehaptic obstruction with imaging (USS/MRCP)
Mx:
- ursodeoxycholic acid (slows progression, symptoms)
- cholestyramine for pruritis
- fat-soluble vitamins
- liver transplant if bili>100
Complications:
- cirrhosis –> portal HTN –> ascites, varices
- osteomalacia, osteoporosis
- HCC 20-fold risk
Barrett’s
lower oesophageal metaplasia (squamous –> columnar), risk of adenocarcinoma 50-100 fold
Short (<3cm) or long (>3cm)
Prev 1/20
RF: GORD, Males (7:1), smoking, obesity
- ETOH not independent RF
Mx:
- high dose PPIs
- endoscopic surveillance (every 3-5 yrs for metaplastic patients)
- endoscopic intervention for dysplasia including radiofrequency ablation (1st line, esp for low-grade) or mucosal resection
Gastrin source, stimuli, actions
Source: G cells in antrum (lowermost part) of stomach
stimuli:
- gastric distension
- vagal stimulation by Gastrin-releasing peptide
- luminal peptides/amino acids
Inhibited by:
- low pH, somatostatin
Actions:
- acid and intrinsic factor secretion by parietal cells
- pepsinogen secretion by chief cells
- increases gastric motility
- stimulates parietal cell maturation
CCK source, stimuli, actions
Source: I cells in upper small intestines
Stimuli: patially digested proteins, triglycerides
Actions:
- secretion of enzyme-rich fluid from pancreas
- gallbladder contraction
- relaxation of sphincter of Oddi
- reduces gastric emptying
- trophic effect on pancreatic acinar cells
- induces satiety
Secretin source, stimuli, actions
Source: S cells in upper small intestine
Stimuli: acidic chyme, fatty acids
Actions:
- bicarb-rich fluid secretion from pancreas and hepatic duct cells
- reduces gastric acid secretion
- trophic effect on pancreatic acinar cells
VIP source, stimuli, actions
Source: small intestine, pancreas
stimuli: neural
actions:
- stimulates pancreatic and intestinal secretion
- inhibits acid secretion
Somatostatin source, stimuli, actions
Source: pancreatic and gastric D cells
Stimuli:
- fat, bile salts, glucose in intestinal lumen
Actions:
- reduces acid, pepsin, gastrin, pancreatic enzyme, insulin, glucagon secretion
- inhibits trophic effects of gastrin
- stimulates gastric mucus production
What foods can Coeliac disease patients have and what to avoid
Gluten - including wheat, barley, rye, oats (some can tolerate)
Can have rice, potatoes, maize/corn
How to check Coeliac gluten-free compliance
TTG abs